tazobactam has been researched along with Microbial Superinvasion in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dizbay, M; Karaşahin, EF; Karaşahin, Ö; Özger, HS | 1 |
| Barie, PS; Cayci, C; Eachempati, SR; Fusco, D; Goldstein, MJ; Huston, JM; Kapur, S; Mathew, M; Rodney, JR; Shou, J | 1 |
| Castillo Caparrós, A; Montijano Cabrera, AM | 1 |
3 other study(ies) available for tazobactam and Microbial Superinvasion
| Article | Year |
|---|---|
Treatment efficacy and superinfection rates in complicated urinarytract infections treated with ertapenem or piperacillin tazobactam.
Topics: Anti-Bacterial Agents; beta-Lactams; Ertapenem; Humans; Penicillanic Acid; Piperacillin; Retrospective Studies; Superinfection; Tazobactam; Treatment Outcome | 2016 |
Treatment of Strongyloides stercoralis hyperinfection-associated septic shock and acute respiratory distress syndrome with drotrecogin alfa (activated) in a renal transplant recipient.
Topics: Aged, 80 and over; Albendazole; Animals; Anti-Infective Agents; Drug Therapy, Combination; Female; Fibrinolytic Agents; Humans; Ivermectin; Kidney Transplantation; Klebsiella Infections; Klebsiella pneumoniae; Penicillanic Acid; Piperacillin; Protein C; Recombinant Proteins; Respiratory Distress Syndrome; Shock, Septic; Strongyloides stercoralis; Strongyloidiasis; Superinfection; Tazobactam; Treatment Outcome | 2009 |
[Candida parapsilosis endocarditis after prolonged antibiotic therapy].
Topics: Candida; Candidiasis; Cardiac Tamponade; Cefazolin; Disease Susceptibility; Drug Therapy, Combination; Endocarditis; Fatal Outcome; Humans; Ischemia; Leg; Male; Middle Aged; Opportunistic Infections; Penicillanic Acid; Piperacillin; Postoperative Complications; Superinfection; Tazobactam | 2002 |